15+ World-Leading Experts Share Their Latest Case Studies & Insights:

Securing, Tracking and Managing Your Product through Efficient Serialisation Strategy Implementation

Medicinal products intended for human use have to be serialised by 2015

Serialisation is no longer a matter of “if”, or even “when”; it’s a matter of how will you implement it effectively

Working with key representatives across the entire supply chain, the 2nd Annual Serialisation & Traceability summit is unique in that it brings you all the stakeholders from across the value cha in.

LAST PLACES REMAINING - DO NOT MISS OUT!
Have a look at who's already attending the event here

With speakers from EFPIA, GS1, APB and PGEU, GIRP and HIBC (yes, all the important acronyms!), as well as AstraZeneca, Roche, Boehringer-Ingelheim, GlaxoSmithKline, Daiichi-Sankyo and Abbott Laboratories, this year’s summit is not to be missed – ensure your serialisation strategy is efficient, effective and compliant with requirements from around the world.

pharma Pharma Serialisation Deadlines
Pharma IQ has created this easy-to-assimilate summary of serialisation requirements around the world, whether they are already being followed or have impending deadlines (e.g. much of Europe due to the Falsified Medicines Act). You can keep it as a handy reference, share it around your colleagues or even stick it on your wall!



Join us in Geneva on November 2-4th 2011 to learn and discuss how to:

  • Analyse and successfully manage the real impact of the Falsified Medicines Directive; identify the key strategic decisions that must be made to improve your anti-counterfeiting on a global scale with keynote speaker Simeon Wilson, Director of Global Security, AstraZeneca
  • Achieve patient safety throughout Europe through serialisation by analysing the realities and additional benefits of serialisation systems with EFPIA representative Grant Courtney, Global Serialisation Lead, GlaxoSmithKline
  • Effectively plan your serialisation strategy by assessing the current capabilities and technological gaps throughout the supply chain with expertise and representation from all of the key stakeholders, including manufacturers (EFPIA), wholesalers (GIRP), pharmacists (APB and PGEU) and standards bodies (GS1 and HIBC)
  • Understand country-by-country interpretations and requirements Internationally including a Daiichi-Sankyo case study from Turkey, and Abbott case study from the USA, experiences in China from Boehringer-Ingelheim, the Italian Ministry of Health and the latest updates on Brazil from Latin America specialists Montesino

Including a brand new Breakfast Briefing on the morning of the 3rd November that will bring you an exclusive round-up of the latest country-by-country interpretations and requirements around the world. If you plan to comply to with the mandatory EU serialisation, you can’t afford to miss this!

Guido_Hoogewijs_video

Guido Hoogewijs - APB Speaks About the Benefits and Pitfalls of Online Authentication
Dr. Guido Hoogewijs, General Manager Association of the Pharmacists of Belgium (APB), shares his insights with Pharma IQ, about pharmaceutical serialisation and traceability. Learn more

Testimonials

Very good choice of speakers panel.
Sebastien Onimus, Alexion Pharma International
Many opportunities for exchange with peers facing the same challenges-highly appreciated.
Sebastien Mauel, Merck Serono
Very valuable to hear how everyone is combating counterfeit.
Nils Just Christensen, H. Lundbeck A/S
Associate Sponsor Sessions Sponsor
123Axway sie_logo_petrol_cmyk
Sessions Sponsor Sessions Sponsor
Schreiner_MediPharm systech
Sessions Sponsor Meeting Sponsor
zetes Kezzlerlogo
Featured Exhibitor Featured Exhibitor
Sign domino
Featured Exhibitor Featured Exhibitor
Travtec-Pharma-Logo-2 Sicpa